Inventor · disambiguated record
Christopher R. Bebbington
Also filed as: BEBBINGTON CHRISTOPHER · BEBBINGTON CHRISTOPHER R · BEBBINGTON CHRISTOPHER ROBERT
54 granted patents·38 pending applications·2,345 citations·filing 1987–2022
99Inventor score
Files withALLAKOS INC19KALOBIOS PHARMACEUTICALS INC18OXFORD BIOMEDICA LTD15MEDAREX INC8BEBBINGTON CHRISTOPHER R7
Top patents by PatentIndex Score
92 records- 0198US5122464AMethod for dominant selection in eucaryotic cellsCELLTECH LTD·Filed 1987·Granted Jun 16, 1992·874 cites·22 claims
- 0297US7303910B2Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 2004·Granted Dec 4, 2007·137 cites·6 claims
- 0396US5827739ARecombinant DNA sequences, vectors containing them and method for the use thereofCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Oct 27, 1998·200 cites·4 claims
- 0495US5770359ARecombinant DNA sequences, vectors containing them and method for the use thereofCELLTECH THERAPEUTICS LTD·Filed 1994·Granted Jun 23, 1998·265 cites·12 claims
- 0594US5591639ARecombinant DNA expression vectorsCELLTECH LTD·Filed 1994·Granted Jan 7, 1997·183 cites·7 claims
- 0693US7981843B2Antibody specificity transfer using minimal essential binding determinantsKALOBIOS PHARMACEUTICALS INC·Filed 2005·Granted Jul 19, 2011·36 cites·14 claims
- 0793US7514546B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2006·Granted Apr 7, 2009·13 cites·25 claims
- 0893US7214663B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2001·Granted May 8, 2007·52 cites·26 claims
- 0993US6897034B2CD10-activated prodrug compoundsMEDAREX INC·Filed 2002·Granted May 24, 2005·52 cites·10 claims
- 1093US6653101B1Recombinant DNA method and host cellsLONZA AG·Filed 2000·Granted Nov 25, 2003·40 cites·13 claims
- 1191US7074909B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2001·Granted Jul 11, 2006·27 cites·13 claims
- 1290US7304032B2CD-10 activated prodrug compoundsMEDAREX INC·Filed 2004·Granted Dec 4, 2007·31 cites·23 claims
- 1390US5658759ARecombinant DNA expression vectorsCELLTECH LTD·Filed 1996·Granted Aug 19, 1997·84 cites·10 claims
- 1489US10604577B2Methods and compositions for treating systemic mastocytosisALLAKOS INC·Filed 2016·Granted Mar 31, 2020·5 cites·10 claims
- 1589US9546215B2Anti-Siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2014·Granted Jan 17, 2017·7 cites·68 claims
- 1689US8084249B2VectorKINGSMAN SUSAN MARY·Filed 2010·Granted Dec 27, 2011·9 cites·6 claims
- 1789US8075885B2Methods of treating heart failure using an anti-GM-CSF antibodyBEBBINGTON CHRISTOPHER R·Filed 2009·Granted Dec 13, 2011·6 cites·28 claims
- 1889US7816317B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2007·Granted Oct 19, 2010·13 cites·26 claims
- 1988US8398972B2Methods of treating dementia using a GM-CSF antagonistBEBBINGTON CHRISTOPHER R·Filed 2010·Granted Mar 19, 2013·9 cites·30 claims
- 2086US7531648B2Vector encoding an antibody that binds 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2002·Granted May 12, 2009·8 cites·13 claims
- 2186US5891693ARecombinant DNA methods vectors and host cellsALUSUISSE HOLDINGS AG·Filed 1995·Granted Apr 6, 1999·77 cites·25 claims
- 2284US7718627B2VectorOXFORD BIOMEDICA LTD·Filed 2006·Granted May 18, 2010·4 cites·24 claims
- 2384US6852703B1Tumor targeted vectorOXFORD BIOMEDICA LTD·Filed 1998·Granted Feb 8, 2005·39 cites·31 claims
- 2483US11203638B2Methods and compositions for treating perennial allergic conjunctivitis and keratoconjunctivitisALLAKOS INC·Filed 2018·Granted Dec 21, 2021·2 cites·23 claims
- 2583US10774145B2Methods and compositions for treating fibrotic diseasesALLAKOS INC·Filed 2016·Granted Sep 15, 2020·3 cites·37 claims
- 2683US10183996B2Methods and compositions for treating Siglec-8 associated diseasesALLAKOS INC·Filed 2015·Granted Jan 22, 2019·6 cites·58 claims
- 2782US8168183B2Antibodies to granulocyte-macrophage colony-stimulating factorBEBBINGTON CHRISTOPHER R·Filed 2009·Granted May 1, 2012·4 cites·36 claims
- 2881US5879936ARecombinant DNA methods, vectors and host cellsALUSUISSE HOLDINGS AG·Filed 1992·Granted Mar 9, 1999·65 cites·9 claims
- 2980US8664365B2Antibodies to EphA3LUEHRSEN KENNETH·Filed 2010·Granted Mar 4, 2014·6 cites·29 claims
- 3079US9017674B2Antibodies to granulocyte-macrophage colony-stimulating factorBEBBINGTON CHRISTOPHER R·Filed 2012·Granted Apr 28, 2015·3 cites·4 claims
- 3179US8828393B2Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonistPICKFORD LESLEY B·Filed 2011·Granted Sep 9, 2014·6 cites·16 claims
- 3278US8211648B2Secretion of antibodies without signal peptides from bacteriaYARRANTON GEOFFREY T·Filed 2005·Granted Jul 3, 2012·2 cites·16 claims
- 3378US7939076B2Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonistMEDAREX INC·Filed 2004·Granted May 10, 2011·9 cites·16 claims
- 3478US7888484B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)MEDAREX INC·Filed 2009·Granted Feb 15, 2011·2 cites·5 claims
- 3578US7619070B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)MEDAREX INC·Filed 2004·Granted Nov 17, 2009·8 cites·17 claims
- 3676US11773162B2Anti-Siglec-7 antibodies for the treatment of cancerALLAKOS INC·Filed 2017·Granted Oct 3, 2023·2 cites·14 claims
- 3775US7276488B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Oct 2, 2007·2 cites·18 claims
- 3873US2023331854A1Methods and compositions for treating systemic mastocytosisALLAKOS INC·Filed 2022·Application pending·0 cites
- 3973US2010040539A1Vector SystemOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 4072US2022331412A1Anti-siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2022·Application pending·0 cites
- 4171US9109032B2Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrowYARRANTON GEOFFREY T·Filed 2012·Granted Aug 18, 2015·1 cites·14 claims
- 4271US7635687B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Dec 22, 2009·2 cites·7 claims
- 4371US5747308ARecombinant DNA methodALUSUISSE HOLDINGS AG·Filed 1995·Granted May 5, 1998·27 cites·13 claims
- 4471US2023303686A1Methods and compositions for treating fibrotic diseasesALLAKOS INC·Filed 2022·Application pending·0 cites
- 4570US8758757B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)CARDARELLI JOSEPHINE M·Filed 2010·Granted Jun 24, 2014·1 cites·16 claims
- 4669US2009017532A1VectorOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 4767US2005032216A1VectorOXFORD BIOMEDICA LTD·Filed 2004·Application pending·0 cites
- 4867US2015030614A1Antibodies to the pcrv antigen of pseudomonas aeruginosaKALOBIOS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4966US6808922B1Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 1998·Granted Oct 26, 2004·14 cites·41 claims
- 5065US8044181B2Antibodies to the PcrV antigen of Pseudomonas aeruginosaKALOBIOS PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·0 cites·15 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →